AG
ICPT

Aperio Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Aperio Group’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$311K Buy
12,575
+2,551
+25% +$84.5K ﹤0.01% 2172
2020
Q3 		$416K Buy
10,024
+4,631
+86% +$213K ﹤0.01% 1916
2020
Q2 		$258K Buy
5,393
+370
+7% +$28.6K ﹤0.01% 2081
2020
Q1 		$316K Sell
5,023
-670
-12% -$60.2K ﹤0.01% 1876
2019
Q4 		$705K Buy
5,693
+661
+13% +$59.2K ﹤0.01% 1625
2019
Q3 		$334K Buy
5,032
+186
+4% +$12.5K ﹤0.01% 1970
2019
Q2 		$386K Buy
4,846
+26
+0.5% +$2.33K ﹤0.01% 1914
2019
Q1 		$539K Buy
4,820
+369
+8% +$40.3K ﹤0.01% 1710
2018
Q4 		$449K Buy
4,451
+182
+4% +$18.9K ﹤0.01% 1744
2018
Q3 		$539K Sell
4,269
-28
-0.7% -$2.96K ﹤0.01% 1724
2018
Q2 		$361K Sell
4,297
-835
-16% -$61.1K ﹤0.01% 1918
2018
Q1 		$316K Buy
+5,132
New +$309K ﹤0.01% 1932
2017
Q3 		– Sell
-1,751
Closed -$212K – 2245
2017
Q2 		$212K Buy
+1,751
New +$203K ﹤0.01% 2075
2016
Q4 		– Sell
-2,194
Closed -$361K – 2139
2016
Q3 		$361K Buy
2,194
+263
+14% +$41.5K ﹤0.01% 1630
2016
Q2 		$276K Sell
1,931
-221
-10% -$32.2K ﹤0.01% 1692
2016
Q1 		$276K Buy
2,152
+512
+31% +$60.5K ﹤0.01% 1701
2015
Q4 		$245K Buy
1,640
+350
+27% +$59.2K ﹤0.01% 1724
2015
Q3 		$214K Buy
1,290
+210
+19% +$46.2K ﹤0.01% 1736
2015
Q2 		$261K Buy
+1,080
New +$288K ﹤0.01% 1719

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Aperio Group's ICPT Position: Q4 2020 in Review

Aperio Group increased its Intercept Pharmaceuticals, Inc. (ICPT) stake by 25% in Q4 2020, buying an estimated $84.5K and bringing the position to 12,575 shares worth $311K. The position accounts for ﹤0.01% of the portfolio, ranked #2172.

Aperio Group first reported a position in ICPT in Q2 2015 and has held it in 19 quarters since. The position peaked at $705K in Q4 2019. 175 funds tracked by Wall St. Rank hold ICPT as of Q4 2020.

  • Aperio Group held 12,575 shares of Intercept Pharmaceuticals, Inc. worth $311K as of Q4 2020.
  • Aperio Group bought 2,551 Intercept Pharmaceuticals, Inc. shares in Q4 2020, an estimated $84.5K.
  • Intercept Pharmaceuticals, Inc. made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2172 holding.
  • Aperio Group first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2015 and has held it in 19 quarters since.
  • Aperio Group's Intercept Pharmaceuticals, Inc. position peaked at $705K in Q4 2019.
  • 175 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.